Research is being conducted on the in vitro activity of omadacycline and eravacycline against certain bacterial isolates. The focus of the studies appears to include Nocardia brasiliensis and nontuberculous mycobacteria, such as Mycobacterium abscessus. The research involves in vitro susceptibility testing and pharmacokinetics/pharmacodynamics of these drugs against these bacteria.